Development updates from across the portfolio. No press-release inflation — dated engineering and clinical milestones as they happen.
Structured outreach plan completed targeting pulmonologists, respiratory therapists, and PF laboratory directors — the first step of the four-stage validation path.
Dr. Ronald J. Swatzyna (Houston Neuroscience Brain Center) concluded structured technical review with a written endorsement of Neura's one-channel EEG methodology.
FHIR R4 service delivered: fourteen endpoints, device-to-FHIR translators across the portfolio, event-sourced storage with audit logging, containerized deployment.
Firmware and analysis codebase hardened: secrets externalized, authentication moved to standard headers, reproducibility fixes, dependency pinning.
Non-dilutive federal application in preparation covering the respiratory and dysphagia programs.
Texas limited liability company established; three-founder structure with defined engineering, finance, and clinical-strategy ownership.